Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

The combination therapy effectively treats infertility in PCOS without major side effects.

CEC levels may be a useful marker for predicting prostate cancer progression.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Kantavallabha rasa may help manage PCOS symptoms effectively.

Platelet-rich plasma may improve hair transplant results.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

PRP injections are a simple, safe, and cost-effective treatment for hair loss.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

PRP may help with female hair loss short-term, but more research is needed for best results.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Platelet-rich plasma (PRP) effectively improves skin aging with minimal risk.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

A new model can predict drug-disease links well, helping drug research.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

The document concludes that more standardized research is needed to fully understand and optimize the use of platelet-rich fibrin in regenerative medicine.

Stand-alone PRP therapy effectively increases hair density for hair loss treatment.

Rheumatoid arthritis can rarely cause bilateral facial nerve palsy linked to p-ANCA positive vasculitis.